Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) with Additional Protein Domain Synthesized in E. coli: In Vivo Osteoinductivity in Experimental Models on Small and Large Laboratory Animals


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Recombinant human bone morphogenetic protein-2 with an additional s-tag domain (s-tag-BMP-2) synthesized in E. coli is characterized by higher solubility and activity than the protein without additional s-tag domain, which increases the yield during purification and simplifies protein introduction into the osteoplastic materials. The high osteoinductivity of the demineralized bone matrix with s-tag-BMP-2 was shown on the model of regeneration of cranial defects of a critical size in mice and on the model of implantation of porous titanium matrix into defects of femoral and tibial bones in rabbits.

作者简介

M. Bartov

N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation

编辑信件的主要联系方式.
Email: mike.bartov@gmail.com
俄罗斯联邦, Moscow

A. Gromov

N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation

Email: mike.bartov@gmail.com
俄罗斯联邦, Moscow

V. Manskih

N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation; A. N. Belozersky Research Institute of Physicochemical Biology, M. V. Lomonosov Moscow State University

Email: mike.bartov@gmail.com
俄罗斯联邦, Moscow; Moscow

E. Makarova

Center of Specialized Types of Medical Care, V.D. Chaklin Ural Institute of Traumatology and Orthopedics

Email: mike.bartov@gmail.com
俄罗斯联邦, Ekaterinburg

A. Rubshtein

M. N. Mikheev Institute of Metal Physics, Ural Division of the Russian Academy of Sciences

Email: mike.bartov@gmail.com
俄罗斯联邦, Ekaterinburg

M. Poponova

N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation

Email: mike.bartov@gmail.com
俄罗斯联邦, Moscow

D. Savina

N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation

Email: mike.bartov@gmail.com
俄罗斯联邦, Moscow

K. Savin

N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation

Email: mike.bartov@gmail.com
俄罗斯联邦, Moscow

K. Nikitin

N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation

Email: mike.bartov@gmail.com
俄罗斯联邦, Moscow

T. Grunina

N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation

Email: mike.bartov@gmail.com
俄罗斯联邦, Moscow

I. Boksha

N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation

Email: mike.bartov@gmail.com
俄罗斯联邦, Moscow

P. Orlova

N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation

Email: mike.bartov@gmail.com
俄罗斯联邦, Moscow

M. Krivozubov

N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation

Email: mike.bartov@gmail.com
俄罗斯联邦, Moscow

M. Subbotina

N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation; All-Russian Research Institute of Agricultural Biotechnology

Email: mike.bartov@gmail.com
俄罗斯联邦, Moscow; Moscow

V. Lunin

N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation; All-Russian Research Institute of Agricultural Biotechnology

Email: mike.bartov@gmail.com
俄罗斯联邦, Moscow; Moscow

A. Karyagina

N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation; A. N. Belozersky Research Institute of Physicochemical Biology, M. V. Lomonosov Moscow State University; All-Russian Research Institute of Agricultural Biotechnology

Email: mike.bartov@gmail.com
俄罗斯联邦, Moscow; Moscow; Moscow

A. Gintsburg

N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of the Russian Federation

Email: mike.bartov@gmail.com
俄罗斯联邦, Moscow


版权所有 © Springer Science+Business Media, LLC, part of Springer Nature, 2017
##common.cookie##